International Edition
Latest News
Health

Standard Dental Labs Acquires Dr. Tooth Assets to Expand Florida Operations

Standard Dental Labs Inc. acquired Dr. Tooth, LLC, a dental laboratory business operating as Sheen Dental Laboratory and Hansen Incarnati, in an asset purchase deal, kr.investing.com reported. The transaction covers substantially all operating assets of the target business…

Oil Prices Rise as Markets Weigh Middle East Supply Recovery and US-Iran Diplomacy

Standard Dental Labs Inc. acquired Dr. Tooth, LLC, a dental laboratory business operating as Sheen Dental Laboratory and Hansen Incarnati, in an asset purchase deal, kr.investing.com reported. The transaction covers substantially all operating assets of the target business and expands the buyer’s customer base within Florida.

Revenue Projections and Combined Figures

Combined with Standard Dental Labs’ previously announced annualized revenue estimate of $822,000, the transaction pushes the company’s projected annualized revenue base past $1.6 million. These figures reflect management projections for 12-month expanded operations rather than forecasted revenue for the 2026 fiscal year.

Production Relocation to Sarasota

Standard Dental Labs plans to shift production from the acquired business to its facility in Sarasota, Florida. The company intends to bring work currently outsourced to China back to its Florida operations to improve quality control and communication with dentists. James D. Brooks, president and chief executive officer of Standard Dental Labs, stated that the focus is bringing this work back to Florida so dentists have direct access to the people fabricating their prosthetics.

Standard Dental Labs Acquires Dr. Tooth Assets to Expand Florida Operations

Management Transition and Performance Terms

Denis Thaxton and Gavin White, former executives of Dr. Tooth, will join the management team at Standard Dental Labs. The company expects these changes to create opportunities to rebuild the acquired business to over $1.1 million in annualized revenue, contingent on current account retention, customer recovery, and a successful production transition. The deal is structured as an asset purchase using a combination of cash and Standard Dental Labs common stock, and it includes performance conditions tied to customer retention revenue.

About the author: Dr Natalie Singh - Health Editor

Board‑certified internal‑medicine physician and MPH. Natalie authored peer‑reviewed studies on infectious disease and served as medical editor. “Dr. Natalie Singh delivers evidence‑based health news, medical breakthroughs, and expert wellness guidance.”